Treatment of heroin dependence: Effectiveness, costs, and benefits of methadone maintenance

Research on Social Work Practice

Volumn 16, Issue 1, 2006, Pages 48-56

  Schilling, Robert ^a,b   Dornig, Katrina ^b   Lungren, Lena ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Benefit cost; Drug abuse; Effectiveness; Methadone

Indexed keywords

EID: 29744445741     PISSN: 10497315     EISSN: 15527581     Source Type: Journal    
DOI: 10.1177/1049731505277059     Document Type: Article

References (59)

1. American Public Health Association. (1997). Support for research on alternative and complementary practices (Policy No. 9714). Available at www.apha.org/legislative/policy/policies.htm
2. Ball, J., & Ross, A. (1991). The effectiveness of methadone maintenance treatment: Patients, programs, services, and outcome. New York: Springer-Verlag.
3. Barnett, P. G. (1999). The cost-effectiveness of methadone maintenance as a health care intervention. Addiction, 94, 479-488.
4. Barnett, P. G., & Hui, S. S. (2000). The cost-effectiveness of methadone maintenance. Mount Sinai Journal of Medicine, 67, 365-374.
5. Booth, B. M., Staton, M., & Leukefeld, C. (2001). Substance use health services research. Substance Use and Misuse, 36, 673-685.
6. Booth, R. E., Crowley, T. J., & Zhang, Y. (1996). Substance abuse treatment entry, retention and effectiveness: Out-of-treatment injection drug users. Drug and Alcohol Dependence, 42, 11-20.
7. Center for Substance Abuse Treatment. (1999). Opioid agonist treatment in the 21st century (Center for Substance Abuse Treatment, Office of Pharmacologic and Alternative Therapies Report). Rockville, MD: Substance Abuse and Mental Health Services Administration.
8. Clark, H. W., Masson, C. L., Delucchi, K. L., Hall, S. M., & Sees, K. L. (2001). Violent traumatic events and drug abuse severity. Journal of Substance Abuse Treatment, 20, 121-127.
9. Condelli, W. S., & Hubbard, R. L. (1994). Relationship between time spent in treatment and client outcomes from therapeutic communities. Journal of Substance Abuse Treatment, 11, 25-33.
10. D'Aunno, T., & Pollack, H. A. (2002). Changes in methadone treatment practices: Results from a national panel study, 1998-2000. Journal of the American Medical Association, 288, 850-856.
11. El-Bassel, N., Gilbert, L., Witte, S., Wu, E., Gaeta, T., Schilling, R., et al. (2003). Intimate partner violence and substance abuse among minority women receiving care from an inner-city emergency department. Women's Health Issues, 13, 16-22.
12. El-Bassel, N., Schilling, R. F., Turnbull, J. E., & Su, K. H. (1993). Correlates of alcohol use among methadone patients. Alcoholism: Clinical and Experimental Research, 17, 681-686.
13. Farmer, R., & Bentley, K. J. (2002). Social workers as medication facilitators. In K. J. Bentley (Ed.), Social work practice in mental health: Contemporary roles, tasks, and techniques (pp. 211-229). Pacific Grove, CA: Brooks/Cole.
14. Fortuin Corsi, K., Kwiatkowski, C. F., & Booth, R. E. (2002, Summer). Predictors of positive outcomes for out-of-treatment opiate injectors recruited into methadone maintenance through street outreach. Journal of Drug Issues. Available at www.findarticles.com/p/articles/mi_qa3733/is_200207/ai_n9105551/ pg_1
15. Fudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., et al. (2003). Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. New England Journal of Medicine, 349, 949-958.
16. Halpin, L. S., Barnett, S. D., & Beachy, J. (2003). Cardiac surgery outcomes. Outcomes Management, 7, 144-147.
17. Hser, Y. I., Hoffman, V., Grella, C. E., & Anglin, M. D. (2001). A 33-year follow-up of narcotics addicts. Archives of General Psychiatry, 58, 503-508.
18. Hubbard, R. L., & French, M. T. (1991). New perspectives on the benefit-cost and cost-effectiveness of drug abuse treatment. NIDA Research Monographs, 113, 94-113.
19. Hubbard, R. L., Marsden, M. E., Rachal, J. V., Harwood, H. J., Cavanaugh, E. R., & Ginzburg, H. (1989). Drug abuse treatment: A national study of effectiveness. Chapel Hill: University of North Carolina Press.
20. Jaudes, P. K., Ekwo, E., & Van Voohrhis, J. (1995). Association of drug abuse and child abuse. Child Abuse and Neglect, 19, 1065-1075.
21. Joseph, H., Stancliffe, S., & Langrod, J. (2000). Methadone maintenance treatment (MMT): A review of historical and clinical issues. Mount Sinai Journal of Medicine, 67, 347-363.
22. King, V. L., Stoller, K. B., Hayes, M., Umbricht, A., Currens, M., Kidorf, M. S., et al. (2002). A multicenter randomized evaluation of methadone medical maintenance. Drug Alcohol Dependence, 65, 137-148.
23. Kosten, T. (1992). Pharmacotherapies. In T. Kosten & H. Kleber (Eds.), Clinician's guide to cocaine addiction: Theory, research, and treatment (pp. 273-289). New York: Guilford.
24. Lester, B. M., Tronick, E. Z., LaGasse, L., Seifer, R., Bauer, C. R., Shankaran, S., et al. (2002). The Maternal Lifestyle Study: Effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics, 110, 1182-1192.
25. Lifschltz, M. H., & Wilson, G. S. (1991). Patterns of growth and development in narcotic-exposed children. NIDA Research Monographs, 114, 323-339.
26. Ling, W., & Wesson, D. R. (2003). Clinical efficacy of buprenorphine: Comparisons to methadone and placebo. Drug and Alcohol Dependence, 70(2), S49-S57.
27. Loneck, B., Garrett, J., & Banks, S. (1997). Engaging and retaining women in outpatient alcohol and other drug treatment. Health and Social Work, 22, 38-46.
28. Longshore, D., Evans, E., Urada, D., Teruya, C., Hardy, M., Hser, Y. I., et al. (2003). Substance Abuse and Crime Prevention Act 2002 Report Los Angeles: UCLA Integrated Substance Abuse Programs.
29. Longshore, D., Hsieh, S., Danila, B., & Anglin, M. D. (1993). Methadone maintenance and needle/syringe sharing. International Journal of Addiction, 28, 983-986.
30. Lowinson, J., Marion, I., Joseph, H., & Dole, V. (1992). Methadone maintenance. In J. Lowinson, P. Ruiz, R. Millman, & J. Langrod (Eds.), Substance abuse: A comprehensive textbook (pp. 550-561). Baltimore: Williams & Wilkins.
31. Lundgren, L. M., Schilling, R. F., Fitzgerald, T., Davis, K., & Amodeo, M. (2003). Parental status of women injection drug users and entry to methadone maintenance. Substance Use and Misuse, 38, 1107-1129.
32. Lundgren, L. M., Schilling, R. F. & Peloquin, S. (2005). Evidenced-based drug treatment practice and the child welfare system: The example of methadone. Social Work, 50(1), 53-63.
33. Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2003). Methadone maintenance therapy versus no opiate replacement therapy for opiate dependence. Cochrane Database Systematic Review. 2003; (2): CD002209. Review. PMID: 12804430 (PubMed - indexed for MEDLINE)
34. Merrill, J. O. (2002). Policy progress for physician treatment of opiate addiction. Journal of General Internal Medicine, 17, 361-368.
35. Miller, W. R., Rollnick, S., & Conforti, K. (Eds.). (2002). Motivational interviewing: Preparing people to change addictive behavior (2nd ed.). New York: Guilford.
36. Mojtabai, R., & Zivin, J. G. (2003). Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: A propensity score analysis. Health Services Research, 38, 233-259.
37. Murphy, S., & Irwin, J. (1992). "Living with the dirty secret": Problems of disclosure for methadone maintenance clients. Journal of Psychoactive Drugs, 24, 257-264.
38. National Institute on Drug Abuse. (2000). Principles of drug addiction treatment: A Research-based guide (NIH Publication No. 00-4180,4). Rockville, MD: U.S. Department of Health and Human Services, National Institute on Health.
39. National Institutes of Health. (1997). Effective medical treatment of opiate addiction (NIH Consensus Statement, November 17-19; 15, 6: 1-38). Kensington, MD: Author.
40. O'Brien, C. P. (1996). Recent developments in the pharmacotherapy of substance abuse. Journal of Consulting and Clinical Psychology, 64, 677-686.
41. Pinkerton, S. D., Holtgrave, D. R., DiFranceisco, W., Semaan, S., Coyle, S. L., & Johnson-Masotti, A. P. (2000). Cost-threshold analyses of the National AIDS Demonstration Research HIV prevention interventions. AIDS, 14, 1257-1268.
42. Rawson, R. A., & Obert, J. L. (2002). The substance abuse treatment system in the U.S. What is it? What does it do? Myths and misconceptions. Occupational Medicine, 17, 27-39.
43. Roebuck, M. C., French, M. T., & McLellan, A. T. (2003). DATSTats: Results from 85 studies using the Drug Abuse Treatment Cost Analysis Program (DATCAP). Journal of Substance Abuse Treatment, 25, 51-57.
44. Royse, D., Leukefeld, C., Logan, T. K., Dennis, M., Wechsber, W., Hoffman, J., et al. (2000). Homelessness and gender in out-of-treatment drug users. American Journal of Drug and Alcohol Abuse, 26, 283-296.
45. Schilling, R. F., & El-Bassel, N. (1998). Substance abuse interventions. In J. B. Williams & K. Ell (Eds.), Advances in mental health research: Implications for practice (pp. 437-481). Washington, DC: NASW Press.
46. Schilling, R. F., Mares, A. S., & El-Bassel, N. (2003). Women in detoxification: Loss of guardianship of their children. Children and Youth Services Review, 25(11), 221-225.
47. Schuckit, M. (1995). Drug and alcohol abuse. New York: Plenum.
48. Sees, K. L., Delucchi, K. L., Masson, C., Rosen, A., Clark, H. W., Robillard, H., et al. (2000). Methadone maintenance vs. 180-day psychosocially enriched detoxification for treatment of opioid dependence. Journal of the American Medical Association, 283, 1303-1310.
49. Sorensen, J. L., & Copeland, A. L. (2000). Drug abuse treatment as an HIV prevention strategy: A review. Drug and Alcohol Dependence, 59, 17-31.
50. Stucker, S. (2000). Drug abuse treatment programs make gains in methadone treatment and HIV prevention. NIDA Notes, 15, 3.
51. Substance Abuse and Mental Health Services Administration. (2003a). The ADSS cost study: Costs of substance abuse treatment in the specialty sector (DHHS Publication No. SMA 03-3762, Analytic Series A-20). Rockville, MD: Office of Applied Studies, Health and Human Services.
52. Substance Abuse and Mental Health Services Administration. (2003b). Planned methadone treatment for heroin admissions (The DASIS Report, June 13). Arlington, VA: Office of Applied Studies, Health and Human Services.
53. Tims, E., Leukefeld, C., & Platt, J. (Eds.). (2001). Relapse and recovery processes in the addictions. New Haven, CT: Yale University Press.
54. Turner, B. J., Newschaffer, C. J., Zhang, D., Fanning, T., & Hauck, W. W. (1999). Translating clinical trial results into practice: The effect of an AIDS clinical trial on prescribed antiretroviral therapy for HIV-infected pregnant women. Annals of Internal Medicine, 130, 979-986.
55. Van Beusekom, I., & Iguchi, M. Y. (2001). A review of recent advances in knowledge about methadone maintenance treatment (MR-1396/ RE/FOPH/DPRC). Leiden, The Netherlands: Drug Policy Research Center, RAND Europe.
56. Vastag, B. (2003). Addiction poorly understood by clinicians: Experts say attitudes, lack of knowledge hinder treatment. Journal of the American Medical Association, 290, 1299-1303.
57. World Health Organization. (2001). Summary of papers: XII International AIDS Conference. Available at www.who.int/HIV_AIDS/ IDU/IDU_summary.html
58. Zaric, G. S., Barnett, P. G., & Brandeau, M. L. (2000). HIV transmission and the cost-effectiveness of methadone maintenance. American Journal of Public Health, 90, 1100-1111.
59. Ziegler, M., Poustka, F., von Loewenich, V., & Englert, E. (2000). Postpartum risk factors in the development of children born to opiate-addicted mothers: Comparison between mothers with and without methadone substitution. Nervenarzt, 71, 730-736.